InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,678.40
(
0.21%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.68
(
-1.51%
)
Bitcoin
60,692.65
(
-3.74%
)
Post# of 5055
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Ubertino

Send PM Follow Ignore
Followers 113
Posts 25553
Boards Moderated 4
Alias Born 02/01/2004

Ubertino

Re: None

Sunday, 01/13/2008 10:55:30 AM

Sunday, January 13, 2008 10:55:30 AM

Post# of 5055
Re Tubercin

International Journal of Dermatology

Volume 41 Issue 1 Page 52-53, January 2002

Abstract
Regression of an acral lentiginous melanoma with an immunotherapy using a Mycobacterium tuberculosis-extracted polysaccharide complex (Tubercin)

* Tai Ho Chung, MD, PhD,
* Jae Bok Jun, MD,
* Jae Won Jang, MD, and
* Hai Lee Chung, MD

*
From the WHO Collaboration Viral Hepatitis Center, Department of Dermatology, School of Medicine, Kyungpook National University, and the Catholic University of Taegu, Taegu, Korea

http://www.blackwell-synergy.com/doi/abs/10.1046/j.0011-9059.2001.01388.x

The SEC Must Go!
And jail shorters.


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up